USPTO serial 99709354
BUILD FOR BREAKTHROUGH
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MILLER, CHARLES FREDERICK
- Law office
- TMO LAW OFFICE 112
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with BUILD FOR BREAKTHROUGH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori P. Hager
88 S Finley Avenue 2nd Fl. Suite ABasking Ridge, NJ 07920United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising agencies specializing in marketing strategies to promote businesses; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Business consulting services relating to the integration of the areas of business process technology, organizational learning, change management, and operational sustainability; Computerized database management; Management and compilation of computerised databases; Business management and consultation in the field of pharmaceuticals; Business advisory services in the field of pharmaceuticals; Business strategic planning services in the field of marketing services and data analysis, in the pharmaceutical industry; Business assistance, management and information services; Information, advisory and consultancy services relating to business and management or business administration, including such services provided on line or via the internet; Consultancy and advisory services in the field of business strategy; Business management consulting and advisory services for the pharmaceutical industry; Business consulting services in the field of business management, workflow and quality in the pharmaceutical industry; Business administration services in the field of pharmaceuticals; Data processing services in the field of pharmaceuticals; Marketing services, namely, consumer marketing research; Marketing forecasting; Marketing services rendered using artificial intelligence (AI); Providing business management information in connection with consulting and advisory services in the field of strategic planning; Business advisory services in the field of pharmaceuticals, namely providing descriptive and predictive analytics; Business advisory services in the field of pharmaceuticals, namely providing formulation of best practices for the pharmaceuticals industry; Preparation of business reports; Business management consultancy services | ACTIVE | — |
| 036 | Strategic corporate financial advisory services; Information, advisory, consultancy and financial research services relating to finance and investments; Financial advisory services; Financial advisory and consultancy services, namely, strategic corporate financial advisory, and investments advisory services; Financial advisory and consultancy services, namely, services related to financial profiles; Financial advisory and consultancy services, namely, financial revenue forecasts | ACTIVE | — |
| 042 | Providing on-line non-downloadable software for predictive analytics in the field of pharmaceuticals; Providing on-line non-downloadable software for managing, accessing and sharing information and data related to performance metrics; Providing on-line non-downloadable software for analyze and select of algorithms for use in predictive analytics in the field of pharmaceuticals; Providing on-line non-downloadable software for creating advertising layout; Providing on-line non-downloadable software for compiling and organizing business intelligence; Software as a service (SAAS) services, namely, hosting software for use by others for use by others for business data analysis, in the field of pharmaceuticals; Software as a service (SAAS) services, namely, hosting software for use by others for use by others for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals, and providing reports; Software as a service (SAAS) services featuring software for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals, and providing reports; Software as a service (SAAS) services featuring software for use in managing, developing, analyzing, summarizing, editing, and sorting data stored in computer database; Software as a service (SAAS) services featuring software for business data analysis, in the field of pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing, developing, analyzing, summarizing, editing, and sorting data stored in computer databases in the field of pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating business analysis reports; Platform as a service (PAAS) featuring computer software platforms for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals and providing reports and alerts concerning such performance; Platform as a service (PAAS) featuring computer software platforms for information processing, namely, software for managing, developing, analyzing, summarizing, editing, and sorting data stored in computer databases; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for tracking performance metrics, data visualizations, and predictive analytics in the field of pharmaceuticals, and providing reports; Computer services in the nature of customized web pages and other data feed formats featuring user-defined information; Platform as a service (PAAS) featuring computer software platforms for business data analysis and predictive analytics, in the field of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 1, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 2, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2026 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| May 21, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 18, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 18, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2026 | NWAP | NEW APPLICATION ENTERED | — |